Veristat Acquires Instat Clinical Research

Veristat Acquires SQN Clinical

February 25, 2021

Healthcare Services

Veristat acquired SQN Clinical to expand its biometrics capabilities and strengthen its European footprint. The acquisition adds more than 80 employees and integrates SQN Clinical's clinical data management, biostatistics and project management capabilities into Veristat's global CRO services.

Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)

January 6, 2020

Healthcare Services

Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.

Veristat Acquires SFL (Solutions for Life Sciences)

March 7, 2022

Healthcare Services

Veristat, a scientific-focused global CRO headquartered in Southborough, Massachusetts, has acquired SFL (Solutions for Life Sciences), a Basel-based multi-disciplinary life sciences consultancy. The acquisition expands Veristat's regulatory affairs, pharmacovigilance, medical writing, market access and quality assurance capabilities in Europe and strengthens its ability to support biopharma and medtech clients entering EU/UK/Swiss markets.

WindRose Health Investors Recapitalizes Veristat Group Inc.

April 7, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.

Verustat Acquires One Healthcare SolutionTM

July 21, 2022

Healthcare Services

Verustat, a Nashville-based remote patient monitoring company, has acquired Texas-based One Healthcare Solution (OneHS) to integrate OneHS's chronic care management software and EMR-integration capabilities into Verustat's RPM platform. The acquisition expands Verustat's product offerings—enabling Chronic Care Management, Annual Wellness Visits, and Medication Reconciliation—to existing and new physician clients and creates new revenue streams.

Medix Biochemica Acquires ViroStat LLC

November 10, 2023

Biotechnology

Medix Biochemica has acquired 100% of ViroStat LLC, a US-based manufacturer of infectious disease antibodies and antigens, expanding Medix's IVD raw materials portfolio and scientific capabilities. ViroStat will continue operating in Westbrook, Maine, and its employees and leadership (including President Dr. Douglas McAllister and General Manager Duncan McAllister) will join Medix Biochemica.